The BCR-ABL-negative myeloproliferative neoplasms (MPN) are clonal myeloid malignancies that rely on constitutive JAK-STAT signaling as a consequence of the JAK2V617F mutation. This evidence concerns the gene ABL1 and myeloproliferative neoplasm.